Christopher Hwang
Hoofd Techniek/Wetenschap/O&O bij TRANSCENTA HOLDING LIMITED
Profiel
Christopher Hwang is currently the Chief Technology Officer & Executive VP at Transcenta Holding Ltd.
Prior to this, he worked at Genzyme Corp.
and Sanofi as a Senior Director from 1992 to 2016.
He received his undergraduate degree from Massachusetts Institute of Technology in 1985 and his doctorate degree from the same institution in 1992.
Actieve functies van Christopher Hwang
| Bedrijven | Functie | Begin |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-02-2019 |
Eerdere bekende functies van Christopher Hwang
| Bedrijven | Functie | Einde |
|---|---|---|
| SANOFI | Directeur/Bestuurslid | 01-09-2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | 01-02-2016 |
Opleiding van Christopher Hwang
| Massachusetts Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| SANOFI | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
